Background Approximately one in three patients with acute ischemic stroke (AIS) suffer from a premorbid disability prior to their incident AIS. These patients have largely been excluded from clinical ...

More patients receiving tenecteplase versus standard medical treatment had excellent functional outcome at 90 days.

Advanced brain imaging is expanding stroke treatment windows, enabling selected patients beyond 24 hours to benefit ...

New research published in the Journal of Stroke and Cerebrovascular Diseases confirms that strokes thought to happen in older adults are possible in the younger (defined as 18–50 years old) population ...

Alteplase, a “clot-buster” medication used to treat ischemic stroke, acute myocardial infarctions, and acute pulmonary ...

Endovascular treatment (EVT) of stroke with large-vessel occlusion is known to be safe and effective. The effect of EVT for occlusion of medium or distal vessels is unclear. We randomly assigned ...

Please provide your email address to receive an email when new articles are posted on . The Open-Motion device will undergo a future validation study to further determine its viability. Large vessel ...

The 2026 International Stroke Conference (ISC), held February 4-6 in New Orleans, Louisiana, delivered potentially ...

Background Off-hour admissions can adversely affect clinical outcomes, though evidence in patients with acute ischemic stroke ...

HELSINKI — In patients with large vessel occlusion stroke treated within 4.5 hours of symptom onset, outcomes were better in those who received the thrombolytic tenecteplase prior to endovascular ...

Left atrial appendage occlusion (LAAO) during cardiac surgery in patients with atrial fibrillation was associated with lower stroke-related disability and reduced risk for 30-day mortality and ...

For patients with non-large vessel occlusion, acute ischemic stroke and salvageable brain tissue, intravenous tenecteplase ...